AQST
Aquestive Therapeutics, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$5.34
−0.19%0
Insider buys (3m)
5
Insider sells (3m)
-$436.8K
Net value (3m)
+37.6%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 18, 2026 | Barber Daniel · director, officer: President and CEO | Sale | 25,000 | $4.29 |
| Aug 17, 2026 | Korczynski Sherry · officer: Chief Commercial Officer | F-InKind | 2,714 | $4.25 |
| Jul 17, 2026 | Barber Daniel · officer: President and CEO | Sale | 20,369 | $4.00 |
| Jul 17, 2026 | Barber Daniel · officer: President and CEO | Sale | 4,631 | $4.03 |
| Jun 24, 2026 | Krop Julie · director | Sale | 25,000 | $5.02 |
| Jun 24, 2026 | Krop Julie · director | M-Exempt | 25,000 | $0.71 |
| Jun 16, 2026 | Barber Daniel · officer: President and CEO | Sale | 25,000 | $4.16 |
| Jun 12, 2026 | Jenkins Abigail L. · director | A-Award | 50,500 | $3.99 |
| Jun 12, 2026 | Cochran John · director | A-Award | 50,500 | $3.99 |
| Jun 12, 2026 | Krop Julie · director | A-Award | 50,500 | $3.99 |
| Jun 12, 2026 | Taglietti Marco · director | A-Award | 50,500 | $3.99 |
| Jun 12, 2026 | MORRIS TIMOTHY E · director | A-Award | 50,500 | $3.99 |
| Jun 12, 2026 | BROWN GREGORY B · director | A-Award | 50,500 | $3.99 |
| Jun 9, 2026 | Korczynski Sherry · officer: Chief Commercial Officer | F-InKind | 2,714 | $0.00 |
| May 19, 2026 | Zalewski Thomas A. · officer: Chief Legal Officer | A-Award | 100,000 | $0.00 |
| May 19, 2026 | Zalewski Thomas A. · officer: Chief Legal Officer | A-Award | 75,000 | $4.13 |
| May 18, 2026 | Barber Daniel · officer: President and CEO | Sale | 8,257 | $4.29 |
| May 18, 2026 | Cioffi Melina · officer: SVP, Regulatory Affairs | F-InKind | 1,667 | $4.17 |
| May 11, 2026 | BRAENDER LORI J · officer: Corporate Secretary | F-InKind | 135,690 | $4.23 |
| May 7, 2026 | Boyd Peter E. · officer: Chief People Officer | F-InKind | 56,778 | $4.18 |
| May 7, 2026 | Barber Daniel · officer: President and CEO | F-InKind | 335,922 | $4.18 |
| May 7, 2026 | TOTH A ERNEST JR · officer: Chief Financial Officer | F-InKind | 92,652 | $4.18 |
| May 7, 2026 | Jung Cassie · officer: Chief Operating Officer | F-InKind | 72,734 | $4.18 |
| May 7, 2026 | BRAENDER LORI J · officer: Corporate Secretary | F-InKind | 76,147 | $4.18 |
| Apr 13, 2026 | Barber Daniel · officer: President and CEO | A-Award | 293,100 | $0.00 |
| Apr 13, 2026 | Boyd Peter E. · officer: Chief People Officer | A-Award | 60,000 | $0.00 |
| Apr 13, 2026 | Jung Cassie · officer: Chief Operating Officer | A-Award | 60,000 | $0.00 |
| Apr 13, 2026 | TOTH A ERNEST JR · officer: SVP, Chief Financial Officer | A-Award | 82,500 | $0.00 |
| Apr 13, 2026 | Korczynski Sherry · officer: Chief Commercial Officer | A-Award | 67,500 | $0.00 |
| Apr 13, 2026 | BRAENDER LORI J · officer: Corporate Secretary | A-Award | 82,500 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 76Increased 126Reduced 93Sold out 18
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BRATTON CAPITAL MANAGEMENT, L.P. | Unchanged | 9,810,958 | May 13, 2026 |
| Bratton Capital Management, L.P. | Unchanged | 9,810,958 | Aug 11, 2026 |
| BlackRock, Inc. | Increased | 8,069,373 | Aug 7, 2026 |
| BLACKROCK, INC. | Reduced | 7,509,071 | May 13, 2026 |
| RTW INVESTMENTS, LP | Increased | 7,426,471 | May 15, 2026 |
| RTW INVESTMENTS, LP | Unchanged | 7,426,471 | Aug 14, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 4,584,533 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 4,443,698 | May 15, 2026 |
| FEDERATED HERMES, INC. | Increased | 3,112,561 | Aug 12, 2026 |
| FEDERATED HERMES, INC. | Increased | 2,940,339 | May 11, 2026 |
| STATE STREET CORP | Increased | 2,928,020 | Aug 7, 2026 |
| BALYASNY ASSET MANAGEMENT L.P. | Increased | 2,900,570 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 2,622,888 | Aug 12, 2026 |
| STATE STREET CORP | Increased | 2,546,191 | May 15, 2026 |
| SAMSARA BIOCAPITAL, LLC | Unchanged | 2,500,000 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 18, 2026